ITU-T H.845.17 PDF

The scope of this Recommendation¹ is to provide a test suite structure (TSS) and the test purposes TPs) for the Personal Health Devices interface based on the requirements defined in Continua Design Guidelines (CDG) [ITU-T H.810 (2017)]. The objective of this test specification is to provide a high probability of interoperability at this interface.

The TSS and TPs for the Personal Health Devices interface have been divided into the parts specified below. This Recommendation covers Part 5, subpart 5Q.

– Part 1: Optimized Exchange Protocol. Personal Health Device

– Part 2: Optimized Exchange Protocol. Personal Health Gateway

– Part 3: Continua Design Guidelines. Personal Health Device

– Part 4: Continua Design Guidelines. Personal Health Gateway

– Part 5: Device Specializations. Personal Health Device. This document is divided into the following subparts:

• Part 5A: Weighing scales

• Part 5B: Glucose meter

• Part 5C: Pulse oximeter

• Part 5D: Blood pressure monitor

• Part 5E: Thermometer

• Part 5F: Cardiovascular fitness and activity monitor

• Part 5G: Strength fitness equipment

• Part 5H: Independent living activity hub

• Part 5I: Adherence monitor

• Part 5J: Insulin pump

• Part 5K: Peak flow

• Part 5L: Body composition analyser

• Part 5M: Basic electrocardiograph

• Part 5N: International normalized ratio monitor

• Part 5O: Sleep apnoea breathing therapy equipment (SABTE)

• Part 5P: Continuous glucose monitor (CGM)

• Part 5Q: Power status monitor (PSM)

– Part 6: Device Specializations. Personal Health Gateway

– Part 7: Continua Design Guidelines. Personal Health Device BLE

– Part 8: Continua Design Guidelines. Personal Health Gateway BLE

– Part 9: Personal Health Devices Transcoding White paper. Personal Health Device

– Part 10: Personal Health Devices Transcoding White paper. Personal Health Gateway

¹ This Recommendation includes an electronic attachment with the protocol implementation extra information for testing (PIXIT) required for the implementation of Annex A.